Board of Advisors

(in the order of last name)

Dr Rob Bryant - Principal, Brychem Business Consulting.

Peter Chua – President, Association of Hong Kong Healthcare Professionals; Member, the Pharmacy & Poisons Board of the Hong Kong Government; President, Huatai Pharmaceutical Ltd., Hong Kong; Director, Beijing United Pharmaceutical Ltd.; Justice of Peace (HK); and former President, Hong Kong Pharmaceutical Society.

Dr. Vivian Chen – Director of Public Policy and Center of Excellence for China, Becton Dickinson; and former Director of Healthcare Economic Policy, RDPAC.

Stanley Lau – President, China Biological Products Inc.; former GM - Baxter China; former GM - Schering Plough China; former GM Asia – Searle/Pharmacia; and former GM MSD – Taiwan

Simon Luo – Director of Operations and Country Manager, IMS Greater China; Board Director, Chinese Hospital Association; Senior Advisor, National Institute of Hospital Administration under the Ministry of Health; Advisor, China Association of Pharmaceutical Commerce; and Advisor, China Association of Chain Drug Stores.

Robert Pollard – Managing Director Asia Pacific, P\S\L Group Market Research; and former Director Synovate Healthcare China.

Dr. Xiaomei Li Reckford, Vice President, China Strategic Growth, Quintiles Transnational Corporation; Former CEO, Quintiles Greater China.

Peter Scheuer – Head of Legal Affairs, Bayer Healthcare China; and Former Executive Director, R&D-based Pharmaceutical Association in China (RDPAC).

Dr. Jiaxiang Shen - Senior Fellow, Chinese Academy of Engineering; Honorary Chairman, the Pharmacy College of Tianjin University; and advisor to many Chinese government agencies; and former Deputy Chief Engineer, State Pharmaceutical Administration of China and Director, National Institutes for Pharmaceutical R&D.

Dr. Yan Yan L Starkey - Director, New Product Research China Liaison at GlaxoSmithKline Consumer Healthcare.

Dr. Dong Xie – Chairman and CEO, Frontier Biotechnology Ltd.

Cheryl Q. Xu – President, Aquila Health Consulting and Advisor on China, Pharmaceutical Research and Manufacturers of America (PhRMA).

Dr. Weiping Yang – Chairman and CEO, Fresenius Kabi China; and Director, RDPAC.